Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

ClinicalTrials.gov ID: NCT02182830

Public ClinicalTrials.gov record NCT02182830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Empagliflozin (10mg, 25mg) Administered Orally, Once Daily Over 24 Weeks in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is designed to investigate the efficacy and safety of empagliflozin compared with placebo in hypertensive black/African Americans with type 2 Diabetes Mellitus. Since hyperglycaemia and hypertension are key risk factors for both micro- and macrovascular complications, assessment of both glucose and BP lowering effects of empagliflozin in hypertensive African American patients with type 2 Diabetes Mellitus could provide clinically highly relevant, new information for the use of empagliflozin. Essential hypertension is four times more common in African Americans than in Caucasians. One of the risk factors for hypertension is sodium sensitivity and approximately one third of the essential hypertensive population is responsive to sodium intake. There is a higher association of hypertension with sodium sensitivity in African American patients with type 2 Diabetes Mellitus. The treatment duration of this trial (24 weeks) will enable assessment of the clinically relevant endpoint of a decrease in HbA1c, a well accepted measurement of chronic glycaemic control and the key secondary endpoints of decreases in systolic BP (SBP) and diastolic BP (DBP) at 12 and 24 weeks.

Study identification

NCT ID
NCT02182830
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
166 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 25, 2014 (Actual)
Primary completion
May 18, 2017 (Actual)
Completion
May 18, 2017 (Actual)
Last update posted
Jul 31, 2018

2014 – 2017

United States locations

U.S. sites
92
U.S. states
25
U.S. cities
65
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205 —
Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC Birmingham Alabama 35211 —
Longwood Research Huntsville Alabama 35801 —
Internal Medicine Center, LLC Mobile Alabama 36608 —
Mobile Medical and Diagnostic Center Mobile Alabama 36617 —
University of South Alabama Mobile Alabama 36617 —
Cardiology and Medicine Clinic Little Rock Arkansas 72204 —
Larry Watkins, M .D. Little Rock Arkansas 72205 —
eStudySite Chula Vista California 91911 —
Torrance Clinical Research Institute Inc. Lomita California 90717 —
Long Beach Center for Clinical Research Long Beach California 90807 —
MD Clinical Trials Los Angeles California 90025 —
Office of Dr. Alexander Ford, M.D. Los Angeles California 90035 —
Diabetes Associates Medical Group Orange California 92868 —
Integrated Research Group, Inc. Riverside California 92506 —
Clinical Trials Research Sacramento California 95821 —
Orange County Research Center Tustin California 92780 —
Lynn Institute of Denver Denver Colorado 80246 —
Pines Clinical Research Inc. Hollywood Florida 33024 —
UF Health Jacksonville Jacksonville Florida 32207 —
Care Partners Clinical Research LLC Jacksonville Florida 32277 —
Sunshine Research Center Opa-locka Florida 33054 —
Central Florida Internist Orlando Florida 32811 —
Accord Clinical Research, LLC Port Orange Florida 32129 —
International Clinical Research - US, LLC Sanford Florida 32771 —
Meridien Research St. Petersburg Florida 33709 —
Alternative Solutions Medical Research and Prevention Center St. Petersburg Florida 33711 —
Meridien Research Tampa Florida 33634 —
Grady Memorial Hospital Atlanta Georgia 30303 —
Morehouse School of Medicine Atlanta Georgia 30310 —
Atlanta Center Atlanta Georgia 30331 —
Atlanta Clinical Research Centers Atlanta Georgia 30342 —
Albert F. Johary MD, PC Dunwoody Georgia 30338 —
Sestron Clinical Research Marietta Georgia 30060 —
Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC Marietta Georgia 30067 —
WR-Mount Vernon Clinical Research, LLC Sandy Springs Georgia 30328 —
Eagle's Landing Diabetes and Endocrinology Stockbridge Georgia 30281 —
Cedar Crosse Research Center Chicago Illinois 60607 —
John H. Stroger Jr. Hospital of Cook Country Chicago Illinois 60612 —
University of Chicago Chicago Illinois 60637 —
Investigators Research Group, LLC Brownsburg Indiana 46112 —
Centex Studies, Inc. Lake Charles Louisiana 70601 —
Gulf Regional Research and Education Services, LLC Metairie Louisiana 70002 —
New Orleans Center for Clinical Research New Orleans Louisiana 70119 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
American Institute of Research Studies Baltimore Maryland 21218 —
Phillips Medical Services, PLLC Jackson Mississippi 39209 —
Mercy Research Washington Missouri 63090-4700 —
Quality Clinical Research Inc Omaha Nebraska 68114 —
Accent Clinical Trials Las Vegas Nevada 89106 —
Lovelace Scientific Resources, Inc. Albuquerque New Mexico 87108 —
Offic of Dr. Eric Cheng Brooklyn New York 11203-1203 —
Healthwise Medical Associates Brooklyn New York 11206 —
Modern Medical Brooklyn New York 11207 —
Erie County Medical Center Buffalo New York 14215 —
Scott Research, Inc. Laurelton New York 11413 —
Medex Healthcare Research, Inc. New York New York 10036 —
Laurelton Heart Specialist, PC Rosedale New York 11422 —
Metrolina Internal Medicine, PA Charlotte North Carolina 28204 —
PhysiqueMed Clinical Trials Greensboro North Carolina 27405 —
Triad Clinical Trials Greensboro North Carolina 27410 —
Peters Medical Research High Point North Carolina 27262 —
High Point Clinical Trials Center High Point North Carolina 27265 —
Coastal Carolina Health Care, P.A. New Bern North Carolina 28562 —
Hometown Urgent Care Columbus Ohio 43214 —
Dayton Clinical Research Dayton Ohio 45406 —
Today Clinical Research, Oklahoma City Oklahoma City Oklahoma 73129 —
Suburban Research Associates Media Pennsylvania 19063 —
Temple University School of Medicine Philadelphia Pennsylvania 19140 —
Medical Research South Charleston South Carolina 29407 —
TLM Medical Services, LLC Columbia South Carolina 29204 —
Amistad Clinical Research Center Columbia South Carolina 29223 —
Greenville Pharmaceutical Rsch Greenville South Carolina 29615 —
Mountain View Clinical Research Greer South Carolina 29651 —
Berkley Family Practice Moncks Corner South Carolina 29461 —
Carolina Cardiology Clinical Research Institute, LLC Rock Hill South Carolina 29732 —
Community Research Partners, Inc Varnville South Carolina 29944 —
Memphis Veterans Affairs Medical Center Memphis Tennessee 38104 —
The Green Clinic PC Memphis Tennessee 38119 —
Southwind Medical Specialists Memphis Tennessee 38125 —
University of Tennessee Memphis Tennessee 38163 —
Diagnostic Clinic of Houston Houston Texas 77004 —
Cullen Family Practice, PLLC Houston Texas 77051 —
Centex Studies, Inc. Houston Texas 77058 —
Texas Center for Drug Development, Inc. Houston Texas 77081 —
Kelsey-Seybold Clinic Houston Texas 77096 —
Hillcrest Family Health Center Waco Texas 76710 —
Millennium Clinical Trials LLC Arlington Virginia 22203 —
York Clinical Research, LLC Norfolk Virginia 23510 —
Dominion Medical Associates, Inc. Richmond Virginia 23219 —
Clinical Research Partners, LLC Richmond Virginia 23235 —
Family Medical Clinic Milwaukee Wisconsin 53216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02182830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02182830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →